Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
0.2053
-0.0080 (-3.75%)
Aug 20, 2026, 2:59 PM EDT - Market open
Catheter Precision Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.64 | 0.09 | 2.87 | 3.57 | 15.86 | 15.05 |
Cash & Short-Term Investments | 1.84 | 0.09 | 2.87 | 3.57 | 15.86 | 15.05 |
Cash Growth | 7.42% | -96.94% | -19.41% | -77.52% | 5.41% | -37.07% |
Receivables | 0.12 | 0.16 | 0.07 | 0.14 | - | 0.02 |
Inventory | 0.09 | 0.09 | 0.03 | 0.04 | - | 0.99 |
Prepaid Expenses | 0.46 | 0.06 | 0.32 | 0.42 | 0.98 | 1.04 |
Total Current Assets | 2.51 | 0.39 | 3.29 | 4.16 | 16.84 | 17.09 |
Property, Plant & Equipment | 2.64 | 0.23 | 0.2 | 0.25 | - | 3.92 |
Other Intangible Assets | 18.6 | 15.24 | 24.27 | 26.32 | - | - |
Other Long-Term Assets | 0.16 | 0.01 | 0.01 | 0.01 | - | 0.04 |
Total Assets | 36.87 | 15.86 | 27.77 | 30.74 | 16.84 | 21.04 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.45 | 1.49 | 0.23 | 0.46 | 0.09 | 0.99 |
Accrued Expenses | 2 | 0.39 | 0.37 | 0.38 | 0.94 | 3.92 |
Short-Term Debt | 7.74 | 0.6 | 0.18 | 0.18 | - | - |
Current Portion of Leases | 1.47 | 0.06 | 0.1 | 0.09 | - | 0.28 |
Other Current Liabilities | 0.65 | 1.36 | 1.36 | 1.36 | 6.55 | 0.2 |
Total Current Liabilities | 13.45 | 3.91 | 2.23 | 2.47 | 7.58 | 5.39 |
Long-Term Debt | 3.29 | 3.08 | 1.56 | - | - | - |
Long-Term Leases | 1.16 | 0.1 | 0.01 | 0.1 | - | 1.98 |
Long-Term Deferred Tax Liabilities | 1.04 | 1.33 | 3.14 | - | - | - |
Other Long-Term Liabilities | 0.79 | 0.79 | 9.07 | 6.97 | - | - |
Total Liabilities | 19.73 | 9.21 | 16.01 | 9.54 | 7.58 | 7.37 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Additional Paid-In Capital | 332.07 | 316.59 | 304.11 | 296.9 | 214.4 | 191.95 |
Retained Earnings | -314.51 | -309.54 | -292.35 | -275.71 | -205.14 | -178.27 |
Total Common Equity | 17.56 | 7.05 | 11.76 | 21.19 | 9.26 | 13.67 |
Minority Interest | -0.42 | -0.4 | - | - | - | - |
Shareholders' Equity | 17.14 | 6.65 | 11.76 | 21.19 | 9.26 | 13.67 |
Total Liabilities & Equity | 36.87 | 15.86 | 27.77 | 30.74 | 16.84 | 21.04 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 13.66 | 3.85 | 1.85 | 0.37 | - | 2.26 |
Net Cash (Debt) | -11.82 | -3.76 | 1.02 | 3.19 | 15.86 | 12.78 |
Net Cash Growth | - | - | -67.93% | -79.87% | 24.08% | -32.81% |
Net Cash Per Share | -5.92 | -3.48 | 5.96 | 110.40 | - | - |
Filing Date Shares Outstanding | 14.39 | 2.69 | 0.49 | 0.04 | 0.03 | - |
Total Common Shares Outstanding | 3.61 | 1.74 | 0.42 | 0.04 | 0.01 | - |
Working Capital | -10.94 | -3.52 | 1.06 | 1.69 | 9.26 | 11.7 |
Book Value Per Share | 4.87 | 4.06 | 27.91 | 573.08 | 814.21 | - |
Tangible Book Value | -14 | -8.18 | -12.52 | -5.13 | 9.26 | 13.67 |
Tangible Book Value Per Share | -3.88 | -4.71 | -29.71 | -138.58 | 814.21 | - |
Machinery | - | 0.23 | 0.19 | 0.1 | - | 4.35 |
Construction In Progress | - | - | - | - | - | 0.17 |
Leasehold Improvements | - | - | - | - | - | 0.15 |